Publications
Use our search bar to find specific articles.
Filter
Filters
Spectrally tailored hyperpixel filter arrays for efficient imaging of chemical compositions
Authors: M Taylor-Williams, R Cousins, C Williams, SE Bohndiek, CJ Mellor, GSD Gordo...
Research group: Bohndiek Group
E-pub date: 2 Mar 2022
Journal name: Progress in Biomedical Optics and Imaging
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
Authors: I Vergote, A González-Martín, I Ray-Coquard, P Harter, N Colombo, P Pujol...
Research group: Brenton Group
E-pub date: 1 Mar 2022
Journal name: Ann Oncol
Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Authors: EO Dareng, JP Tyrer, DR Barnes, MR Jones, X Yang, KKH Aben, MA Adank, S Aga...
Research group: Brenton Group
E-pub date: 1 Mar 2022
Journal name: Eur J Hum Genet
Opti-MSFA: a toolbox for generalized design and optimization of multispectral filter arrays.
Authors: TW Sawyer, M Taylor-Williams, R Tao, R Xia, C Williams, SE Bohndiek
Research group: Bohndiek Group
E-pub date: 28 Feb 2022
Journal name: Opt Express
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer.
Authors: KGM Aspros, JM Carter, TL Hoskin, VJ Suman, M Subramaniam, MJ Emch, Z Ye, Z...
Research group: Carroll Group
E-pub date: 17 Feb 2022
Journal name: NPJ Breast Cancer
Early Neutrophilia Marked by Aerobic Glycolysis Sustains Host Metabolism and Delays Cancer Cachexia.
Authors: M Petruzzelli, M Ferrer, MJ Schuijs, SO Kleeman, N Mourikis, Z Hall, D Pere...
Research group: Halim Group
E-pub date: 15 Feb 2022
Journal name: Cancers (Basel)
Abstract GS1-00: Single-cell spatial analysis by imaging mass cytometry and immunotherapy response in triple-negative breast cancer (TNBC) in the NeoTRIPaPDL1 trial
Authors: G Bianchini, XQ Wang, E Danenberg, C-S Huang, D Egle, M Callari, B Bermejo,...
Research group: Ali Group
E-pub date: 15 Feb 2022
Journal name: Cancer Research
Divinylpyrimidine reagents generate antibody-drug conjugates with excellent in vivo efficacy and tolerability.
Authors: SJ Walsh, S Omarjee, FM Dannheim, D-L Couturier, D Bexheti, L Mendil, G Cro...
Research group: Carroll Group
E-pub date: 8 Feb 2022
Journal name: Chem Commun (Camb)